V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240011741 | 240007952 | 1.75 | null | null | 2015-04-28 | 2015-05-08 | PACLITAXEL | N | N | 240032045 | PACLITAXEL |
| 240011742 | 240007953 | 1.65 | 43.4 | Palliative (P) | 2018-03-09 | 2018-03-09 | null | 01 | N | 240032061 | NOT MATCHED |
| 240011743 | 240014287 | 1.67 | 62.3 | Disease modification (D) | 2014-08-21 | 2014-08-21 | Azacitidine | N | Y | 240032076 | AZACITIDINE |
| 240011744 | 240007956 | 1.53 | 50.9 | Curative (C) | 2018-12-01 | 2018-12-01 | Bevacizumab | 02 | N | 240032085 | BEVACIZUMAB |
| 240011745 | 240007957 | 1.7 | 64.7 | Curative (C) | null | 2013-12-04 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 240032094 | PACLITAXEL |
| 240011746 | 240007959 | null | null | Palliative (P) | 2016-08-13 | 2016-08-16 | Methotrexate intrathecal | Y | N | 240032094 | METHOTREXATE INTRATHECAL |
| 240011747 | 240007960 | null | 67.9 | Curative (C) | 2016-11-20 | 2016-11-28 | INTERLACE TRIAL | N | null | 240032111 | INTERLACE TRIAL |
| 240011748 | 240007961 | 1.55 | 63.6 | Curative (C) | 2014-02-09 | 2014-02-12 | ALCL ALCL 99 Closed AM 1, 2 or 3 | 1 | N | 240032123 | NOT MATCHED |
| 240011749 | 240007963 | 1.88 | 59.25 | Disease modification (D) | 2016-11-04 | 2016-11-05 | Carboplatin AUC 2 - 5 | N | N | 240032123 | CARBOPLATIN |
| 240011750 | 240012264 | 1.65 | 84 | Adjuvant (A) | 2017-02-24 | 2017-03-03 | Trial Unspecified | N | N | 240032128 | TRIAL |
| 240011751 | 240007966 | 1.74 | 34.4 | Palliative (P) | 2017-06-01 | 2017-06-22 | Azacitidine | N | N | 240032129 | AZACITIDINE |
| 240011752 | 240007967 | 1.62 | 66.2 | Curative (C) | 2013-10-20 | 2013-11-17 | Azacitidine | N | null | 240032142 | AZACITIDINE |
| 240011753 | 240007969 | 1.75 | 70.5 | Palliative (P) | 2014-05-15 | 2014-12-21 | ALCL ALCL 99 Closed AM 1, 2 or 3 | 01 | N | 240032145 | NOT MATCHED |
| 240011754 | 240007970 | 0 | 103 | Disease modification (D) | 2017-10-09 | 2017-10-09 | Azacitidine | 02 | N | 240032146 | AZACITIDINE |
| 240011755 | 240007970 | 1.68 | null | Palliative (P) | 2014-02-01 | 2014-03-13 | Azacitidine | 02 | N | 240032146 | AZACITIDINE |
| 240011756 | 240012267 | 1.54 | 53.6 | Palliative (P) | 2017-08-17 | 2017-08-21 | Trial Unspecified | N | N | 240032156 | TRIAL |
| 240011757 | 240007975 | 1.69 | 68.3 | Curative (C) | 2018-06-12 | 2018-06-12 | CHEMO-T TRIAL | N | N | 240032166 | TRIAL |
| 240011758 | 240014290 | 0 | 63.4 | Curative (C) | 2016-10-28 | 2016-10-28 | Trial Unspecified | N | N | 240032168 | TRIAL |
| 240011759 | 240007976 | 1.8 | 97.8 | Palliative (P) | 2016-04-01 | 2016-04-17 | Bevacizumab+Carbo+Pacliaxel | N | N | 240032168 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011760 | 240007977 | 1.66 | 97.5 | Curative (C) | 2014-09-24 | 2014-09-25 | NHL Int B NHL rit 2010 | 2 | N | 240032183 | NOT MATCHED |
| 240011761 | 240014292 | 0 | 142.7 | Curative (C) | 2015-08-10 | 2015-08-17 | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE PREDNISOLONE | N | N | 240032185 | CHOP |
| 240011762 | 240007979 | null | 76 | Curative (C) | 2016-06-19 | 2016-06-19 | INTERLACE TRIAL | 2 | N | 240032191 | INTERLACE TRIAL |
| 240011763 | 240007980 | null | 57.9 | Palliative (P) | 2015-07-17 | 2015-08-30 | ALCL ALCL 99 Closed BM 1, 2 or 3 | N | N | 240032191 | NOT MATCHED |
| 240011764 | 240007981 | 1.7 | 86 | null | 2014-07-22 | 2014-07-30 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 240032196 | PACLITAXEL |
| 240011765 | 240012273 | 1.69 | 73.6 | Palliative (P) | 2015-08-19 | 2015-08-19 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 240032199 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011766 | 240014294 | 1.68 | 117 | Curative (C) | 2012-10-03 | 2012-10-12 | INTERLACE TRIAL | N | N | 240032200 | INTERLACE TRIAL |
| 240011767 | 240007982 | 1.65 | 102.6 | Curative (C) | 2015-05-27 | 2015-06-03 | ALCL ALCL 99 Closed AM 1, 2 or 3 | 2 | N | 240032202 | NOT MATCHED |
| 240011768 | 240007982 | 1.56 | 74.4 | Curative (C) | 2014-02-02 | 2014-07-21 | Bevacizumab 7.5mg/kg | N | N | 240032202 | BEVACIZUMAB |
| 240011769 | 240007982 | 1.67 | 79.9 | Curative (C) | 2013-12-05 | 2013-12-15 | Methotrexate intrathecal | N | N | 240032202 | METHOTREXATE INTRATHECAL |
| 240011770 | 240007982 | 1.6 | 67.2 | Curative (C) | null | 2019-02-28 | Bevacizumab+Carbo+Pacliaxel | N | null | 240032202 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011771 | 240007983 | null | 49.2 | Palliative (P) | 2013-11-16 | 2013-12-07 | Bevacizumab 15mg/kg | Y | N | 240032218 | BEVACIZUMAB |
| 240011772 | 240014296 | 1.62 | 25 | Palliative (P) | 2016-05-31 | 2016-07-14 | Bevacizumab+Carbo+Pacliaxel | N | N | 240032218 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011773 | 240014296 | 1.57 | 66.35 | Curative (C) | 2015-08-08 | 2015-08-12 | null | 2 | N | 240032218 | NOT MATCHED |
| 240011774 | 240014296 | 1.69 | 70.2 | Palliative (P) | null | 2013-12-10 | Azacitidine | N | N | 240032218 | AZACITIDINE |
| 240011775 | 240016255 | null | 64 | Palliative (P) | 2014-05-24 | 2014-06-04 | Trial Unspecified | N | N | 240032251 | TRIAL |
| 240011776 | 240007984 | 0 | 125 | null | null | 2018-08-21 | Paclitaxel 7 day | 02 | N | 240032251 | PACLITAXEL |
| 240011777 | 240007985 | 1.5 | null | Neo-adjuvant (N) | 2014-08-06 | 2014-08-13 | Bevacizumab 15mg/kg | 02 | N | 240032261 | BEVACIZUMAB |
| 240011778 | 240014297 | 1.71 | 45 | Curative (C) | 2017-03-31 | 2017-04-01 | Paclitaxel 7 day | null | null | 240032263 | PACLITAXEL |
| 240011779 | 240015319 | 1.75 | 42.9 | Curative (C) | 2014-01-04 | 2014-01-24 | EW EuroEwing 2012 Arm A VAC | N | N | 240032272 | NOT MATCHED |
| 240011780 | 240007986 | 1.7 | 42.9 | Curative (C) | null | 2014-11-12 | ALCL ALCL 99 Closed AM 1, 2 or 3 | N | N | 240032272 | NOT MATCHED |
| 240011781 | 240007987 | 1.58 | 63.4 | Curative (C) | 2016-10-19 | 2017-05-15 | AML Downs haM | N | N | 240032277 | NOT MATCHED |
| 240011782 | 240007988 | 1.52 | null | Palliative (P) | 2014-07-14 | 2014-12-06 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 240032277 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011783 | 240007989 | 1.77 | 116 | Palliative (P) | 2017-10-28 | 2017-11-18 | Paclitaxel 7 day | N | N | 240032285 | PACLITAXEL |
| 240011784 | 240007990 | 1.64 | 83 | Palliative (P) | 2018-08-16 | 2018-08-22 | Carboplatin AUC 6 - 10 | 02 | N | 240032286 | CARBOPLATIN |
| 240011785 | 240007990 | 1.58 | null | Curative (C) | 2015-03-26 | 2015-03-30 | ALCL ALCL 99 Closed BM 1, 2 or 3 | 02 | N | 240032286 | NOT MATCHED |
| 240011786 | 240007990 | null | 0 | Palliative (P) | 2013-09-27 | 2013-09-27 | Paclitaxel (2 or 3 weekly) | 2 | N | 240032286 | PACLITAXEL |
| 240011787 | 240007991 | 1.7 | null | Palliative (P) | null | 2017-12-07 | Carboplatin AUC 2 - 5 | Y | N | 240032290 | CARBOPLATIN |
| 240011788 | 240007991 | 0 | 81.3 | Disease modification (D) | 2016-05-01 | 2016-05-10 | Trial Unspecified | N | N | 240032290 | TRIAL |
| 240011789 | 240007991 | 1.68 | 78.9 | Palliative (P) | null | 2018-06-11 | Paclitaxel 7 day | N | N | 240032290 | PACLITAXEL |
| 240011790 | 240007991 | 1.75 | 101 | Neo-adjuvant (N) | 2015-09-04 | 2015-09-04 | Bevacizumab | N | N | 240032290 | BEVACIZUMAB |